TCR2 Therapeutics (TCRR) PT Raised to $32 at Wedbush

July 27, 2020 6:20 AM EDT
Get Alerts TCRR Hot Sheet
Price: $12.86 +1.34%

Rating Summary:
    10 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 25 | New: 41
Trade Now! 
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $32.00 (from $25.00) while maintaining a Outperform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change